Exclusive: San Diego biotech raises $11.7M to use cells as targeted delivery vessels for genetic medicines

Ryan Cross

Senior Science Correspondent

Cytonus Therapeutics, a small biotech company north of San Diego, raised $11.7 million in Series A financing to engineer cells as delivery vessels for genetic …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Exclusive: San Diego biotech raises $11.7M to use cells as targeted delivery vessels for genetic medicines

Ryan Cross

Senior Science Correspondent

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

BridgeBio’s heart disease drug Attruby sails past prescription estimates

Can amylin drugs take over from GLP-1s in obesity? Partnerless Zealand thinks so

Will CRISPR matter?

RFK Jr. readies review of childhood vaccine schedule after pledging not to

Pfizer CEO says opportunities with Trump ‘clearly outweigh’ the risks for pharma

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Ex­clu­sive: San Diego biotech rais­es $11.7M to use cells as tar­get­ed de­liv­ery ves­sels for ge­net­ic med­i­cines

Senior Science Correspondent

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Exclusive: San Diego biotech raises $11.7M to use cells as targeted delivery vessels for genetic medicines